These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3060442)

  • 41. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis.
    Chang TT; Gulati SC; Chou TC; Vega R; Gandola L; Ibrahim SM; Yopp J; Colvin M; Clarkson BD
    Cancer Res; 1985 Jun; 45(6):2434-9. PubMed ID: 3857119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro purging of human rhabdomyosarcoma cells using 4-hydroperoxycyclophosphamide.
    Ozkaynak MF; Nolta J; Parkman R
    Cancer Res; 1990 Mar; 50(5):1455-8. PubMed ID: 2302710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancer.
    Ross AA; Miller GW; Moss TJ; Kahn DG; Warner NE; Sweet DL; Louie KG; Schneidermann E; Pecora AL; Meagher RC
    Bone Marrow Transplant; 1995 Jun; 15(6):929-33. PubMed ID: 7581093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autologous bone marrow support and bone disease in metastatic breast cancer.
    Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM
    Can J Oncol; 1995 Dec; 5 Suppl 1():33-9. PubMed ID: 8853522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-T cell immunotoxins containing pokeweed anti-viral protein: potential purging agents for human autologous bone marrow transplantation.
    Ramakrishnan S; Uckun FM; Houston LL
    J Immunol; 1985 Nov; 135(5):3616-22. PubMed ID: 3900212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients.
    Lillo R; Ramírez M; Alvarez A; Santos S; García-Castro J; Fernández de Velasco J; Avilés MJ; Gómez-Pineda A; Díez JL; Balas A; Vicario JL; Bueren JA; García-Sánchez F
    Cancer Res; 2002 Sep; 62(17):5013-8. PubMed ID: 12208755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
    De Fabritiis P; Pulsoni A; Sandrelli A; Simone F; Amadori S; Meloni G; Mandelli F
    Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use.
    Kvalheim G; Sørensen O; Fodstad O; Funderud S; Kiesel S; Dörken B; Nustad K; Jakobsen E; Ugelstad J; Pihl A
    Bone Marrow Transplant; 1988 Jan; 3(1):31-41. PubMed ID: 3048468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dye-mediated photosensitization of murine neuroblastoma cells.
    Sieber F; Sieber-Blum M
    Cancer Res; 1986 Apr; 46(4 Pt 2):2072-6. PubMed ID: 3512078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro and in vivo effects of a monoclonal antibody-toxin conjugate for use in autologous bone marrow transplantation for patients with breast cancer.
    Coombes RC; Buckman R; Forrester JA; Shepherd V; O'Hare MJ; Vincent M; Powles TJ; Neville AM
    Cancer Res; 1986 Aug; 46(8):4217-20. PubMed ID: 3524802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of amifostine in bone marrow purging.
    Cagnoni PJ; Jones RB; Bearman SI; Ross M; Hami L; Franklin WA; Capizzi R; Schein PS; Shpall EJ
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):44-8. PubMed ID: 8783666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro chemoseparation of leukemic cells from murine bone marrow using VP16-213: importance of stem cell assays.
    Stiff PJ; Koester AR
    Exp Hematol; 1987 Mar; 15(3):263-8. PubMed ID: 3545881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Use of photodynamic therapy for elimination of residual leukemic cells in autologous transplants of hematopoietic progenitor cells].
    Hrkal Z; Grebenová D; Cajthamlová H; Soucek J; Bartosová J; Fuchs O; Marinov I; Kobylka P; Klamová H; Sponerová D
    Cas Lek Cesk; 2002 Sep; 141 Suppl():41-6. PubMed ID: 12428422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamide.
    Shimazaki C; Inaba T; Murakami S; Fujita N; Nakagawa M; Gulati SC; Fried J; Clarkson BD; Wisniewolski R; Wang CY
    Prog Clin Biol Res; 1990; 333():311-9. PubMed ID: 2308988
    [No Abstract]   [Full Text] [Related]  

  • 56. [Technical aspects of autologous bone marrow transplantation].
    Handgretinger R; Klingebiel T; Niethammer D
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():39-41. PubMed ID: 7841779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 4-hydroperoxycyclophosphamide--purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia.
    Rizzieri DA; Talbot JT; Long GD; Vredenburgh JJ; Gasparetto C; Smith CS; Colvin MO; Adams D; Morris A; Dodge R; Loftis J; Waters-Pick B; Reese M; Carawan H; Koh LP; Chao NJ
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):183-8. PubMed ID: 12652469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Etoposide as an in vitro purging agent for the treatment of acute leukemias and lymphomas in conjunction with autologous bone marrow transplantation.
    Ciobanu N; Paietta E; Andreeff M; Papenhausen P; Wiernik PH
    Exp Hematol; 1986 Aug; 14(7):626-35. PubMed ID: 3525202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of hypothermia to autologous stem cell purging.
    Miyagi K; Yamazaki T; Tsujino I; Takahashi N; Koya Y; Masutani M; Sawada U; Horie T
    Cryobiology; 2001 May; 42(3):190-5. PubMed ID: 11578118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement.
    Morishima Y; Miyamura K; Kojima S; Ueda R; Morishita Y; Sao H; Tanimoto M; Ohno R; Sobue R; Hirano M
    Bone Marrow Transplant; 1993 Apr; 11(4):255-9. PubMed ID: 7683550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.